Brainstorm Cell Financials
| GHDN Stock | EUR 2.69 0.00 0.00% |
Brainstorm |
Understanding current and past Brainstorm Cell Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Brainstorm Cell's financial statements are interrelated, with each one affecting the others. For example, an increase in Brainstorm Cell's assets may result in an increase in income on the income statement.
Brainstorm Cell Stock Summary
Brainstorm Cell competes with PSI Software, FARO Technologies, ASURE SOFTWARE, G III, and NetSol Technologies. Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of central nervous system adult stem cell therapies designed to address the unmet medical needs of patients with debilitating neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was founded in 2000 and is headquartered in New York, New York. BRAINSTORM operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 31 people.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | US10501E2019 |
| Business Address | 1325 Avenue of |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.brainstorm-cell.com |
| Phone | 201 488 0460 |
| Currency | EUR - Euro |
You should never invest in Brainstorm Cell without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Brainstorm Stock, because this is throwing your money away. Analyzing the key information contained in Brainstorm Cell's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Brainstorm Cell Key Financial Ratios
There are many critical financial ratios that Brainstorm Cell's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Brainstorm Cell Ther reports annually and quarterly.| Return On Equity | -1.93 | |||
| Return On Asset | -0.68 | |||
| Target Price | 11.5 | |||
| Number Of Employees | 43 | |||
| Beta | -0.36 |
Brainstorm Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Brainstorm Cell's current stock value. Our valuation model uses many indicators to compare Brainstorm Cell value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Brainstorm Cell competition to find correlations between indicators driving Brainstorm Cell's intrinsic value. More Info.Brainstorm Cell Therapeutics is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Brainstorm Cell's earnings, one of the primary drivers of an investment's value.Brainstorm Cell Ther Systematic Risk
Brainstorm Cell's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Brainstorm Cell volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Brainstorm Cell Ther correlated with the market. If Beta is less than 0 Brainstorm Cell generally moves in the opposite direction as compared to the market. If Brainstorm Cell Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Brainstorm Cell Ther is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Brainstorm Cell is generally in the same direction as the market. If Beta > 1 Brainstorm Cell moves generally in the same direction as, but more than the movement of the benchmark.
Brainstorm Cell December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Brainstorm Cell help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Brainstorm Cell Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Brainstorm Cell Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Brainstorm Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Brainstorm Cell's daily price indicators and compare them against related drivers.
| Information Ratio | (0.22) | |||
| Maximum Drawdown | 26.05 | |||
| Value At Risk | (6.03) | |||
| Potential Upside | 3.97 |
Complementary Tools for Brainstorm Stock analysis
When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |